_demand-soars-for-novo-nordisk39s-weight-loss-drug-wegovy-despite-supply-constraints-and-eli-lilly-competition.jpg "Demand Soars For Novo Nordisk's Weight-Loss Drug Wegovy Despite Supply Constraints And Eli Lilly Competition from l 2212 2 cgct Video Screenshot Preview")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
⏲ Duration: 1:0
👁 View: 245K times
✓ Published: 02-May-2024
👁 View: 245K times
✓ Published: 02-May-2024
Description:
Novo Nordisk is witnessing a surge in the number of patients starting on its weight-loss drug, Wegovy, in the U.S. This increase comes despite supply constraints and competition from Eli Lilly.<br/>The Danish pharmaceutical company is now shipping more introductory doses of Wegovy to the U.S., as it grapples with supply constraints and competition from Eli Lilly, reported Bloomberg on Friday.
Novo Nordisk is witnessing a surge in the number of patients starting on its weight-loss drug, Wegovy, in the U.S. This increase comes despite supply constraints and competition from Eli Lilly.<br/>The Danish pharmaceutical company is now shipping more introductory doses of Wegovy to the U.S., as it grapples with supply constraints and competition from Eli Lilly, reported Bloomberg on Friday.
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
_cours-de-droit-administratif-introduction-et-notions-clefs.webp "Aideauxtd - Vidéos de droit")
_cmmc-scoping-for-level-2.webp "Kieri")
_but-de-marwan-l-team-b.webp "But de Marwan L - Team B from l 2212 2 cgct")
_ud897-l4-a05-l-http2-improvements.webp "Udacity")
_cours-de-droit-administratif-introduction-et-notions-clefs.jpg)
_cmmc-scoping-for-level-2.jpg)
_but-de-marwan-l-team-b.jpg)
_ud897-l4-a05-l-http2-improvements.jpg)
![[+]](/images/menu.gif){kind=small}